Basic Information
| RNALocate ID: | RLID:11000818 |
| RNA Symbol: | hsa-miR-23a-3p |
| Localization: | Extracellular vesicle |
RNA Information
| RNA Name: | hsa-miR-23a |
| RNA ID: | miRBase:MIMAT0000078 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22849433 |
| Tissue/Cell Line: | HEK-293T cells |
| Method: | Next-generation RNA sequencing |
| Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001321 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001322 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001323 | Mitochondrion | Myotube | 27396686 |
| RLID:01001324 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001325 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001326 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001327 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001328 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11000805 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000806 | Exosome | Pooled sera | 27278097 |
| RLID:11000807 | Exosome | LAC cell line (A549) | 27492069 |
| RLID:11000808 | Exosome | Saliva | 19627513 |
| RLID:11000809 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000810 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000811 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000812 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000813 | Exosome | Ovarian follicular fluid | 22116803 |
| RLID:11000814 | Exosome | Brain tissue | 23382797 |
| RLID:11000815 | Exosome | Plasma | 23663360 |
| RLID:11000816 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000817 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11000819 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000820 | Microvesicle | Plasma | 23077538 |
| RLID:11000821 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000015 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Tongue tissue | |
| RLID-D:11000277 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-23a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-31866 |
| MNDR | hsa-miR-23a-3p | Colorectal adenoma | MNDR-E-MI-31867 |
| MNDR | hsa-miR-23a-3p | Tongue squamous cell carcinoma | MNDR-E-MI-31868 |
| MNDR | hsa-miR-23a-3p | Oral squamous cell carcinoma | MNDR-E-MI-31869 |
| MNDR | hsa-miR-23a-3p | Large cell neuroendocrine cancer | MNDR-E-MI-31870 |
| MNDR | hsa-miR-23a-3p | Medulloblastoma | MNDR-E-MI-31871 |
| MNDR | hsa-miR-23a-3p | B cell lymphoma of malt type | MNDR-E-MI-31872 |
| MNDR | hsa-miR-23a-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-31873 |
| MNDR | hsa-miR-23a-3p | Lymphoma | MNDR-E-MI-31874 |
| MNDR | hsa-miR-23a-3p | Acute promyelocytic leukemia | MNDR-E-MI-31875 |
| MNDR | hsa-miR-23a-3p | Anencephaly | MNDR-E-MI-31876 |
| MNDR | hsa-miR-23a-3p | Niemann-pick disease type c | MNDR-E-MI-31877 |
| MNDR | hsa-miR-23a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-31878 |
| MNDR | hsa-miR-23a-3p | Prostate cancer | MNDR-E-MI-31879 |
| MNDR | hsa-miR-23a-3p | Gastric cancer | MNDR-E-MI-31880 |
| MNDR | hsa-miR-23a-3p | Leukodystrophy metachromatic | MNDR-E-MI-31881 |
| MNDR | hsa-miR-23a-3p | Alzheimer disease | MNDR-E-MI-31882 |
| MNDR | hsa-miR-23a-3p | Dysautonomia familial | MNDR-E-MI-31883 |
| MNDR | hsa-miR-23a-3p | Myotonic dystrophy | MNDR-E-MI-31884 |
| MNDR | hsa-miR-23a-3p | Head and neck cancer | MNDR-E-MI-31885 |
| MNDR | hsa-miR-23a-3p | Vogt-koyanagi-harada disease | MNDR-E-MI-31886 |
| MNDR | hsa-miR-23a-3p | Leukemia | MNDR-E-MI-31887 |
| MNDR | hsa-miR-23a-3p | Huntington disease | MNDR-E-MI-31888 |
| MNDR | hsa-miR-23a-3p | Chorea | MNDR-E-MI-31889 |
| MNDR | hsa-miR-23a-3p | Cardiovascular disease | MNDR-E-MI-31890 |
| MNDR | hsa-miR-23a-3p | Carotid stenosis | MNDR-E-MI-31891 |
| MNDR | hsa-miR-23a-3p | Moyamoya disease | MNDR-E-MI-31892 |
| MNDR | hsa-miR-23a-3p | Lung cancer | MNDR-E-MI-31893 |
| MNDR | hsa-miR-23a-3p | Down syndrome | MNDR-E-MI-31894 |
| MNDR | hsa-miR-23a-3p | Fragile x syndrome | MNDR-E-MI-31895 |
| MNDR | hsa-miR-23a-3p | Parkinson disease | MNDR-E-MI-31896 |
| MNDR | hsa-miR-23a-3p | Niemann-pick disease | MNDR-E-MI-31897 |
| MNDR | hsa-miR-23a-3p | Colonic adenomas | MNDR-E-MI-31898 |
| MNDR | hsa-miR-23a-3p | Breast cancer | MNDR-E-MI-31899 |
| MNDR | hsa-miR-23a-3p | Pancreatic cancer | MNDR-E-MI-31900 |
| MNDR | hsa-miR-23a-3p | Melanoma | MNDR-E-MI-31901 |
| MNDR | hsa-miR-23a-3p | Lesch-nyhan syndrome | MNDR-E-MI-31902 |
| MNDR | hsa-miR-23a-3p | Nephroblastoma | MNDR-E-MI-31903 |
| MNDR | hsa-miR-23a-3p | Colon cancer | MNDR-E-MI-31904 |
| MNDR | hsa-miR-23a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-31905 |
| MNDR | hsa-miR-23a-3p | Familial ovarian cancer | MNDR-E-MI-31906 |
| MNDR | hsa-miR-23a-3p | Prostate adenocarcinoma | MNDR-E-MI-31907 |
| MNDR | hsa-miR-23a-3p | Carcinoma ductal breast | MNDR-E-MI-31908 |
| MNDR | hsa-miR-23a-3p | Glioblastoma | MNDR-E-MI-31909 |
| MNDR | hsa-miR-23a-3p | Astrocytoma | MNDR-E-MI-31910 |
| MNDR | hsa-miR-23a-3p | Glioma | MNDR-E-MI-31911 |
| MNDR | hsa-miR-23a-3p | Chordoma | MNDR-E-MI-31912 |
| MNDR | hsa-miR-23a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-31913 |
| MNDR | hsa-miR-23a-3p | Osteosarcoma | MNDR-E-MI-31914 |
| MNDR | hsa-miR-23a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-31915 |
| MNDR | hsa-miR-23a-3p | Meningioma | MNDR-E-MI-31916 |
| MNDR | hsa-miR-23a-3p | Liver cancer | MNDR-E-MI-31917 |
| MNDR | hsa-miR-23a-3p | Uterine cancer | MNDR-E-MI-31918 |
| MNDR | hsa-miR-23a-3p | Cervical adenocarcinoma | MNDR-E-MI-31919 |
| MNDR | hsa-miR-23a-3p | Gastric adenocarcinoma | MNDR-E-MI-31920 |
| MNDR | hsa-miR-23a-3p | Lung squamous cell carcinoma | MNDR-E-MI-31921 |
| MNDR | hsa-miR-23a-3p | Non-small cell lung cancer | MNDR-E-MI-31922 |
| MNDR | hsa-miR-23a-3p | Lung adenocarcinoma | MNDR-E-MI-31923 |
| MNDR | hsa-miR-23a-3p | Thyroid carcinoma | MNDR-E-MI-31924 |
| MNDR | hsa-miR-23a-3p | Ovarian carcinoma | MNDR-E-MI-31925 |
| MNDR | hsa-miR-23a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-31926 |
| MNDR | hsa-miR-23a-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-31927 |
| MNDR | hsa-miR-23a-3p | Carcinoma renal cell | MNDR-E-MI-31928 |
| MNDR | hsa-miR-23a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-31929 |
| MNDR | hsa-miR-23a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-31930 |
| MNDR | hsa-miR-23a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-31931 |
| MNDR | hsa-miR-23a-3p | Cholangiocarcinoma | MNDR-E-MI-31932 |
| MNDR | hsa-miR-23a-3p | Esophageal cancer | MNDR-E-MI-31933 |
| MNDR | hsa-miR-23a-3p | Lung small cell carcinoma | MNDR-E-MI-31934 |
| MNDR | hsa-miR-23a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-31935 |
| MNDR | hsa-miR-23a-3p | T acute lymphoblastic leukemia | MNDR-E-MI-31936 |
| MNDR | hsa-miR-23a-3p | Acute t cell leukemia | MNDR-E-MI-31937 |
| MNDR | hsa-miR-23a-3p | Heart failure | MNDR-E-MI-31938 |
| MNDR | hsa-miR-23a-3p | Fibromyalgia | MNDR-E-MI-31939 |
| MNDR | hsa-miR-23a-3p | Adenoma | MNDR-E-MI-31940 |
| MNDR | hsa-miR-23a-3p | Breast invasive carcinoma | MNDR-E-MI-31941 |
| MNDR | hsa-miR-23a-3p | Hepatocellular carcinoma | MNDR-E-MI-31942 |
| MNDR | hsa-miR-23a-3p | Familiar ovarian carcinoma | MNDR-E-MI-31943 |
| MNDR | hsa-miR-23a-3p | B-cell lymphoma | MNDR-E-MI-31944 |
| MNDR | hsa-miR-23a-3p | Rheumatoid arthritis | MNDR-E-MI-31945 |
| MNDR | hsa-miR-23a-3p | Barrett's adenocarcinoma | MNDR-E-MI-31946 |
| MNDR | hsa-miR-23a-3p | Osteoarthritis | MNDR-E-MI-31947 |
| MNDR | hsa-miR-23a-3p | Hodgkin lymphoma | MNDR-E-MI-31948 |
| MNDR | hsa-miR-23a-3p | Ulcerative colitis | MNDR-E-MI-31949 |
| MNDR | hsa-miR-23a-3p | Burkitt lymphoma | MNDR-E-MI-31950 |
| MNDR | hsa-miR-23a-3p | Tonsil cancer | MNDR-E-MI-31951 |
| MNDR | hsa-miR-23a-3p | Acute myelogenous leukemia | MNDR-E-MI-31952 |
| MNDR | hsa-miR-23a-3p | Colorectal cancer | MNDR-E-MI-31953 |
| MNDR | hsa-miR-23a-3p | Nasopharynx carcinoma | MNDR-E-MI-31954 |
| MNDR | hsa-miR-23a-3p | Type 2 diabetes mellitus | MNDR-E-MI-31955 |
| MNDR | hsa-miR-23a-3p | Acute lymphocytic leukemia | MNDR-E-MI-31956 |
| MNDR | hsa-miR-23a-3p | Ependymoma | MNDR-E-MI-31957 |
| MNDR | hsa-miR-23a-3p | Cardiomegaly | MNDR-E-MI-31958 |
| MNDR | hsa-miR-23a-3p | Nasopharyngeal cancer | MNDR-E-MI-31959 |
| MNDR | hsa-miR-23a-3p | Prostatic neoplasms | MNDR-E-MI-31960 |
| MNDR | hsa-miR-23a-3p | Sleep deprivation | MNDR-E-MI-31961 |
| MNDR | hsa-miR-23a-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-31962 |
| MNDR | hsa-miR-23a-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-31963 |
| MNDR | hsa-miR-23a-3p | Venous thromboembolism | MNDR-E-MI-31964 |
| MNDR | hsa-miR-23a-3p | Stroke lacunar | MNDR-E-MI-31965 |
| MNDR | hsa-miR-23a-3p | Barrett's carcinogenesis | MNDR-E-MI-31966 |
| MNDR | hsa-miR-23a-3p | Tubulovillous adenoma | MNDR-E-MI-31967 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | APAF1 | Homo sapiens | RR00088393 |
TOP